GEZIELTE IMMUNKONJUGATE
European patent · EP2467165 · In force
Register entry
- Publication number
- EP2467165
- Application number
- EP10744911
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Aug 13, 2010
- Published
- Jun 27, 2012
- Granted
- Jan 7, 2015
- Protection ends at the latest
- Aug 12, 2030
- Next annual fee due
- Aug 31, 2027
- IPC classes
- A61K 47/48 (2006.01)C07K 16/00 (2006.01)C07K 16/18 (2006.01)C07K 16/40 (2006.01)C07K 16/46 (2006.01)A61K 39/00 (2006.01)
- Priority
- US 234584 P 17.08.2009EP 10162410 10.05.2010
- PCT application
- PCT/EP2010/061810 13.08.2010
- PCT publication
- WO2011/020783 24.02.2011
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.08.2026 → 31.08.2027
Published in Swissreg on 01.09.2026
- Sep 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.08.2025 → 31.08.2026
Published in Swissreg on 01.09.2025
- Sep 1, 2024
Next annual fee due on
- Next annual fee due on
- 31.08.2024 → 31.08.2025
Published in Swissreg on 01.09.2024
- Sep 1, 2023
Change
Published in Swissreg on 01.09.2023
- Sep 1, 2022
Change
Published in Swissreg on 01.09.2022
- Jul 2, 2021
Address changed
- Owner
- Roche Glycart AG, Wagistrasse 18, 8952 Schlieren-Zuerich → Roche Glycart AG, Wagistrasse 10, 8952 Schlieren
Published in Swissreg on 02.07.2021
- Jan 7, 2015
Granted
Published in Swissreg on 07.01.2015
Parties
Inventor
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.